CytoSorbents Announces 2020 Financial and Operational Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. LITE
2. CRWD
3. REGN
4. AAPL
5. ABBV
6. MRVL
7. CL
8. LYB
9. TFII
10. ORCL

Go back to CytoSorbents Announces 2020 Financial and Operational Results

Cytosorbents (CTSO) Reports Q4 Revenues Beat

March 9, 2021 4:21 PM EST

Cytosorbents (NASDAQ: CTSO) reported Q4 revenue for the quarter came in at $12 million versus the consensus estimate of $10.95 million.

Q4 2020 Results

Q4 2020 total revenue was approximately $12.0 million versus $7.4 million a year agoProduct sales growth accelerated in Q4 2020, with record quarterly product sales of approximately $11.5 million, a 74% increase from $6.6 million in Q4 2019Product gross margins were a record high of 82% in Q4 2020 versus 80% in Q4 2019

Dr. Phillip Chan, MD, PhD, Chief Executive Officer of CytoSorbents stated, "In our recent stockholder letter, I discussed how the company successfully navigated a... More